Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment
Authors:
- 18 March 2020
- journal article
- research article
- Published by Springer Nature in European Radiology
- Vol. 30 (8) , 4182-4192
Abstract
Objectives Magnetic resonance elastography (MRE) is a non-invasive tool for measuring liver stiffness (LS) with high diagnostic accuracy. This study investigated whether quantified LS by MRE could predict early recurrence of patients with hepatocellular carcinoma (HCC) within the Milan criteria. Methods A prospectively collected cohort, which included the HCC patients who underwent MRE before treatment (an HCC-MRE cohort), was analyzed. In the HCC-MRE cohort, only patients under the Milan criteria, who underwent hepatic resection, radiofrequency ablation (RFA), or transarterial chemoembolization (TACE), were reviewed. We investigated whether LS assessed by MRE was an independent predictor of early recurrence using Cox regressions and Kaplan-Meier analyses. Results A total of 192 HCC patients under the Milan criteria who underwent hepatic resection (n = 96), RFA (n = 23), or TACE (n = 73) were included. Higher LS ratings (kPa; hazard ratio [HR] = 1.12; 95% confidence interval [CI] = 1.01–1.25; p = 0.040) emerged as an independent risk factor for early tumor recurrence. In the subgroup analysis, higher LS ratings were associated with higher risks of early HCC recurrence in both the resection/RFA group (> 4.5 kPa; HR = 2.95; 95% CI = 1.26–6.94; p = 0.013) and the TACE group (> 6 kPa; HR = 2.94; 95% CI = 1.27–6.83; p = 0.012). Conclusion LS assessed by MRE was an independent predictor of early recurrence among HCC patients under the Milan criteria after achieving a complete response. Key Points • Liver parenchymal stiffness measured by MRE predicts early recurrence of treated HCC under Milan criteria. • A liver stiffness > 5.5 kPa was associated with worse recurrence-free survival. • Patients with high pre-treatment LS may benefit from stringent follow-up.Keywords
Funding Information
- Bio & Medical Technology Development Program of the NRF funded by the Korean government (NRF- 2018M3A9E8023861)
- The Bio & Medical Technology Development Program of the NRF funded by the Korean Government (NRF- 017R1D1A1B03033996)
- The Bio & Medical Technology Development Program of the NRF funded by the Korean Government (NRF- 2017R1D1A1B03029959)
- The New Faculty Research Fund of Ajou University School of Medicine (2018)
This publication has 32 references indexed in Scilit:
- Liver stiffness measured by magnetic resonance elastography as a risk factor for hepatocellular carcinoma: a preliminary case–control studyEuropean Radiology, 2012
- Non-Invasive markers for hepatic fibrosisBMC Gastroenterology, 2011
- Liver precancerous lesions and hepatocellular carcinoma: The histology reportDigestive and Liver Disease, 2011
- Prognostic Value of Ishak Fibrosis Stage: Findings From the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis TrialHepatology, 2010
- Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonanceJournal of Hepatology, 2009
- Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography†Hepatology, 2009
- Liver biopsy†Hepatology, 2009
- Magnetic Resonance Elastography for the Noninvasive Staging of Liver FibrosisGastroenterology, 2008
- MR Elastography of Liver Tumors: Preliminary ResultsAmerican Journal of Roentgenology, 2008
- Assessment of Hepatic Fibrosis With Magnetic Resonance ElastographyClinical Gastroenterology and Hepatology, 2007